An easy-to-use dry-powder inhaler.
The mometasone furoate dry-powder inhaler is a novel device designed to support compliance by delivering a topical corticosteroid in a simple three-step operation. This breath-actuated inhaler uses a stabilized agglomerate formulation to measure and deliver accurate, uniform, and precise doses of drug over a range of inspiratory flow rates. Laboratory and clinical data have shown that the design produced a simple, clinically effective inhaler for the treatment of adults and children 12 years of age and older with mild, moderate, or severe persistent asthma.
Karpel
J P
JP
Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA.
D000280:Administration, Inhalation; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000737:chemistry; D001249:Asthma / Q000145:classification / Q000188:drug therapy*; D002626:Chemistry, Pharmaceutical; D004867:Equipment Design; D006801:Humans; D000068656:Mometasone Furoate; D009330:Nebulizers and Vaporizers / Q000145:classification / Q000592:standards* / Q000600:supply & distribution; D011208:Powders; D011244:Pregnadienediols / Q000008:administration & dosage* / Q000737:chemistry; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D011208:Powders; D011244:Pregnadienediols; D000068656:Mometasone Furoate